NEW YORK (Reuters Health) – Survival among women diagnosed with breast cancer when they are pregnant is comparable to that for nonpregnant women of reproductive age treated for…
NEW YORK (Reuters Health) – A meta-analysis of 25 studies has confirmed an increased risk of cancer among children born after fertility treatment. However, “Our results do not…
Leonardo Pignataro, PhD, delves into the latest research on neuroscience and alcohol consumption. Pignataro’s research shows that even small quantities of alcohol affect gene expression through regulation of…
NEW YORK (Reuters Health) – A European study indicates that patients with T-cell prolymphocytic leukemia may respond well to induction chemotherapy using fludarabine, mitoxantrone and cyclophosphamide, followed by…
By David Douglas NEW YORK (Reuters Health) – Surgical resection of isolated pulmonary metastases can prolong overall survival in breast cancer patients, German researchers say. “On the basis…
NEW YORK (Reuters Health) – For women with HER2-positive breast cancer, trastuzumab is as beneficial in those with invasive lobular disease as those with invasive ductal carcinoma, according…
NEW YORK (Reuters Health) – A European study indicates that patients with T-cell prolymphocytic leukemia may respond well to induction chemotherapy using fludarabine, mitoxantrone and cyclophosphamide, followed by…
NEW YORK (Reuters Health) – Environmental factors appear to influence the incidence of papillary thyroid microcarcinomas (PTMCs), according to a comparison of epidemiologic data from Sicily and the…
NEW YORK (Reuters Health) – In a randomized controlled trial, the anti-CA-125 vaccine abagovomab did not prolong survival in patients with ovarian cancer in first remission — despite…
NEW YORK (Reuters Health) – Even without conventional conditioning and cytoxic chemotherapy, an allogeneic hematopoietic cell transplant (HCT) can have a substantial benefit in patients with advanced hematologic…
